About Verman
Verman is a Healthcare company based in Kerava (Finland) founded in 1987. It operates as a residential apartments and flats are developed in various configurations. Verman has completed 1 acquisition, including AAVALABS. Verman offers products and services including Melatonin Supplements, Allergy Medicines, and Vitamin Products. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is Verman-Pharma osaühing.
Company details
Verman was founded in 1987 and is based in Kerava, Finland. Residential properties, including 1, 2, and 3 BHK units, are constructed in ready-to-occupy and upcoming projects within the real estate sector. Emphasis is placed on quality construction and pricing that remains accessible. Developments are positioned across multiple areas to address different customer preferences, with standard amenities incorporated into the designs.
- Investments & Acquisitions
Products & Services of Verman
Verman offers a comprehensive portfolio of products and services, including Melatonin Supplements, Allergy Medicines, and Vitamin Products.
Products to support sleep and nukahtaminen for better rest.
Medicines for managing allergy symptoms and related issues.
Vitamins and hivenaineet for daily health and well-being support.
People of Verman
13 people are tracked at Verman (5 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Janne Kovalainen | Head Of Professional Sales | Leadership |
Juha Teikari | Head Of Commercial Operations Finland | Leadership |
Veera Eskelä | Head Of People And Culture | Leadership |
Aki Savonen | Head Of Production | Leadership |
Minja Miettinen | Director Product Portfolio І Member Of Group Management Team | Leadership |
Sari Iija | Category Manager | Team |
Virpi Natri | Brand & Consumer Engagement Manager | Team |
Anna Rantanen | Sales Operations Specialist, Trade Marketing And Hospital Tenders | Team |
Elisa Särkilahti | Business Development Manager | Team |
Mikko Ikonen | Senior Product Development Manager/ Product Development Unit Leader | Team |
Kalle Hurme | Key Account Manager | Team |
Meri Miettinen | Quality And Regulatory Team Leader | Team |
Hanna-Kaisa Erkkilä | Project Manager | Team |
Complete people profiles for Verman
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verman
Verman has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AAVALABS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Natural supplements and vitamins are provided for multiple health disorders. | aavalabs.com | Helsinki, Finland | 2011 | Dec 2020 | •••• |
Complete acquisition details for Verman
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Verman
2 dated milestones of Verman across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Verman is founded.
- Acquisition Acquires AAVALABS.
Web traffic of Verman
The website of Verman (verman.fi) receives about 6.4K visits a month and ranks #3,395,642 among all websites worldwide, #4,445 in Biotechnology and Pharmaceuticals.
- Monthly visits6.4K
▲ 3.4% vs previous month
- Unique visitors2.5K
per month
- Global rank#3,395,642
among all websites
- Category rank#4,445
Health · Biotechnology and Pharmaceuticals
- Bounce rate64%
- Pages per visit1.5
- Average visit15 sec
- DevicesDesktop 22% · Mobile 78%
Websites whose visitors overlap most with Verman. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ikainstituutti.fi | ikainstituutti.fi | 100% | – | #1,208,740 | – |
uniliitto.fi | uniliitto.fi | 99% | – | #1,369,004 | – |
terveurheilija.fi | terveurheilija.fi | 95% | – | #3,391,428 | – |
oloapteekki.fi | oloapteekki.fi | 76% | – | #134,528 | – |
| apteekkituotteet.fi | 74% | – | #1,291,033 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Verman
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Verman (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Verman
Verman was founded in 1987.
Verman is headquartered in Kerava, Finland.
Verman was founded in 1987 and is based in Kerava, Finland. Residential properties, including 1, 2, and 3 BHK units, are constructed in ready-to-occupy and upcoming projects within the real estate sector. Emphasis is placed on quality construction and pricing that remains accessible. Developments are positioned across multiple areas to address different customer preferences, with standard amenities incorporated into the designs.
Verman offers Melatonin Supplements, Allergy Medicines, and Vitamin Products.
Verman has made 1 acquisition, including AAVALABS.
Verman operates through Verman-Pharma Osaühing.